Join our facebook page for discussions and further good quality learning :
https://www.facebook.com/groups/405813783372378/
Pharmacology Made Simple : Erythromycin
Erythromycin is an antibiotic useful for the treatment of a number of bacterial infections.
https://www.facebook.com/groups/405813783372378/
Pharmacology Made Simple : Erythromycin
Erythromycin is an antibiotic useful for the treatment of a number of bacterial infections.
This includes respiratory tract infections, skin
infections, chlamydia infections, pelvic inflammatory disease, and syphilis.
It
may also be used during pregnancy to prevent Group B streptococcal infection in
the newborn.
Erythromycin may be used to improve delayed stomach emptying. It
can be given intravenously and by mouth.
An eye ointment is routinely recommended after delivery to
prevent eye infections in the newborn.
Mechanism of Action :
Erythromycin displays bacteriostatic activity or inhibits
growth of bacteria, especially at higher concentrations .It binds to the 50s
subunit of the bacterial rRNA complex, protein synthesis and subsequent
structure and function processes critical for life or replication are
inhibited.
Erythromycin interferes with aminoacyl translocation,
preventing the transfer of the tRNA bound at the A site of the rRNA complex to
the P site of the rRNA complex. Without this translocation, the A site remains
occupied, thus the addition of an incoming tRNA and its attached amino acid to
the nascent polypeptide chain is inhibited.
This interferes with the production
of functionally useful proteins, which is the basis of this antimicrobial
action.
Side Effects:
It is generally safe in those who are allergic to
penicillin.
Erythromycin also appears to be safe to use during
pregnancy.While generally regarded as safe during breastfeeding its use by the
mother during the first two weeks of life may increase the risk of pyloric
stenosis in the baby.
Common side effects include abdominal cramps, vomiting, and
diarrhea. More serious side effects may include Clostridium difficilecolitis,
liver problems, prolonged QT, and allergic reactions.
This risk also applies if taken directly by the baby during
this age.
It is in the macrolide family and works by decreasing
bacterial protein production.
Interactions:
Erythromycin is metabolized by enzymes of the cytochrome
P450 system, in particular, by isozymes of the CYP3A superfamily, CYP3A.
The activity of the CYP3A enzymes can be induced or
inhibited by certain drugs (e.g. dexamethasone) which can cause it to affect
the metabolism of many different drugs, e.g. erythromycin. If other CYP3A
substrates — drugs that are broken down by CYP3A such as simvastatin (Zocor), lovastatin
(Mevacor), or atorvastatin (Lipitor)—are taken concomitantly with erythromycin,
levels of the substrates increase, often causing adverse effects.
A noted drug interaction involves erythromycin and
simvastatin, resulting in increased simvastatin levels and the potential for
rhabdomyolysis. Another group of CYP3A4 substrates are drugs used for migraine
such as ergotamine and dihydroergotamine; their adverse effects may be more
pronounced if erythromycin is associated.
Earlier case reports on sudden death prompted a study on a
large cohort that confirmed a link
between erythromycin, ventricular tachycardia,
and sudden cardiac death in patients also taking drugs that prolong the
metabolism of erythromycin (like verapamil or diltiazem) by interfering with
CYP3A4.
Hence, erythromycin should not be administered to people
using these drugs, or drugs that also prolong the QT interval. Other examples
include terfenadine (Seldane, Seldane-D), astemizole (Hismanal), cisapride
(Propulsid, withdrawn in many countries for prolonging the QT time) and
pimozide (Orap). Theophylline, which is used mostly in asthma, is also
contraindicated.
Erythromycin and doxycycline can have a synergistic effect
when combined and kill bacteria (E. coli) with a higher potency than the sum of
the two drugs together.
This synergistic relationship is only temporary. After
approximately 72 hours, the relationship shifts to become antagonistic, whereby
a 50/50 combination of the two drugs kills less bacteria than if the two drugs
were administered separately.
No comments:
Post a Comment